InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Pepose Jay, Director. Insider active across 1 companies, notably Ocuphire Pharma, Inc.. Cumulatively, 4 filings have been published. Total volume traded: €155k. The latest transaction was filed on 13 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€26,6208,250 shares@ €3.226734.4% of flow
Common Stock
SEC:0001140361-21-041622·
Ideal exit: 9 Sept 2022 (T+270)
€26,6208,250 shares@ €3.226717.2% of flow
Common Stock
SEC:0001140361-21-041622:0·
Ideal exit: 9 Sept 2022 (T+270)
€50,79412,631 shares@ €4.021365.6% of flow
Common Stock
SEC:0001140361-21-031308·
Ideal exit: 10 Jun 2022 (T+270)
€50,79412,631 shares@ €4.021332.8% of flow
Common Stock
SEC:0001140361-21-031308:0·
Ideal exit: 10 Jun 2022 (T+270)
4 of 4 declarations
About Pepose Jay
Jay Pepose serves as a Board Member at Ocuphire Pharma, Inc. In this role, he participates in the governance of the company, providing his expertise to assist in strategic decision-making. His experience in the pharmaceutical sector allows him to contribute to the company's direction and performance improvement.
